Literature DB >> 15616951

Electron beam CT scan is a valuable and safe imaging tool for the pediatric surgical patient.

Anita Talisetti1, Vladimir Jelnin, Carlos Ruiz, Eunice John, Enrico Benedetti, Giuliano Testa, Ai-Xuan L Holterman, Mark J Holterman.   

Abstract

PURPOSE: Electron beam computed tomography (EBCT) is a relatively new technology that has been used primarily to detect coronary artery calcification in adult patients. EBCT has several potential advantages over traditional CT: (1) fast acquisition times resulting in less need for sedation, (2) decreased radiation exposure, and (3) robust software enabling real-time interactive 3-dimensional visualization of anatomic relationships. In this series of case reports, the authors describe their initial experience with the use of EBCT in pediatric noncardiac imaging.
METHODS: Children with a variety of thoracic and abdominal disease processes were evaluated by EBCT.
RESULTS: All patients underwent EBCT scanning without the need for sedation, and 3-dimensional images of the data sets were rendered in minutes after their acquisition. The diagnostic images provided equivalent spatial resolution to the multislice CT scanner but without motion artifacts and lower radiation exposure.
CONCLUSIONS: EBCT is a safe, effective, and user- and patient-friendly alternative to traditional CT in the care of pediatric surgical diseases. The diagnostic yield of EBCT will continue to improve with new technologic advances and clinical experience.

Entities:  

Mesh:

Year:  2004        PMID: 15616951     DOI: 10.1016/j.jpedsurg.2004.08.024

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  1 in total

1.  Electron-beam CT as a diagnostic modality in pediatric nephrology and renal transplant surgery.

Authors:  Ulf H Beier; Eunice John; Adisorn Lumpaopong; Jennifer G Co; Vladimir Jelnin; Enrico Benedetti; Giuliano Testa; Ramona Bottke; Bruce I Sharon; Carlos E Ruiz
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.